Go Pro
→ Trump's Next Move Could Shrink Your Dollar (From Priority Gold) (Ad)tc pixel Free CRBU Stock Alerts

Caribou Biosciences (CRBU) Short Interest Ratio & Short Volume

Caribou Biosciences logo
$1.66 +0.01 (+0.61%)
As of 04:00 PM Eastern
Compare

Caribou Biosciences Short Interest Overview

As of July 15, 2026, Caribou Biosciences (CRBU) had a short interest of 11.59 million shares sold short, representing 12.78% of the public float. This marks a 20.45% increase in short interest since the prior report. The short interest ratio (days to cover) is 4.9, meaning it would take 4.9 days of the average trading volume of 1.39 million shares to cover all short positions.

Current Short Interest
11,594,287 shares
Previous Short Interest
9,625,837 shares
Change Vs. Previous Month
20.45%
Dollar Volume Sold Short
$20.06 million
Short Interest Ratio
4.9 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
99,180,000 shares
Short Percent of Float
12.78%
Today's Trading Volume
758,006 shares
Average Trading Volume
1,385,889 shares
Today's Volume Vs. Average
55%
Short Selling Caribou Biosciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Caribou Biosciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CRBU Short Interest Over Time

CRBU Days to Cover Over Time

CRBU Percentage of Float Shorted Over Time

Caribou Biosciences Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202611,594,287 shares $20.06 million +20.5%12.8%4.92 $1.73
6/30/20269,625,837 shares $16.94 million +27.8%10.6%3.05 $1.76
6/15/20267,531,658 shares $12.50 million +1.1%8.3%4.15 $1.66
5/29/20267,450,323 shares $17.58 million +4.4%8.2%4.05 $2.36
5/15/20267,136,627 shares $15.27 million +0.2%7.9%4.52 $2.14
4/30/20267,123,813 shares $13.39 million +5.3%7.9%4.35 $1.88
4/15/20266,768,285 shares $14.89 million +4.6%7.5%5.49 $2.20
3/31/20266,472,632 shares $12.30 million -8.3%7.1%6 $1.90
3/13/20267,057,089 shares $13.27 million -2.4%8.1%6.17 $1.88
2/27/20267,232,010 shares $13.74 million -6.9%8.0%4.92 $1.90
2/13/20267,768,220 shares $12.27 million +3.2%8.6%5.74 $1.58
1/30/20267,530,609 shares $10.62 million +10.9%8.9%6.88 $1.41
1/15/20266,793,288 shares $10.60 million +4.5%8.0%6.8 $1.56
12/31/20256,501,051 shares $10.34 million +4.2%7.7%6.45 $1.59
12/15/20256,240,758 shares $10.67 million +1.6%7.4%6.48 $1.71
11/28/20256,140,242 shares $12.00 million +9.3%7.3%5.86 $1.96
11/14/20255,618,833 shares $11.18 million +58.4%6.6%0.64 $1.99
10/31/20253,546,605 shares $8.58 million -3.4%4.2%4.54 $2.42
10/15/20253,670,000 shares $10.42 million -9.8%4.5%3.2 $2.84
9/30/20254,070,000 shares $9.48 million -1.0%5.0%3.2 $2.33
9/15/20254,110,000 shares $7.52 million +2.0%5.0%2.9 $1.83
8/31/20254,030,000 shares $7.54 million +3.6%4.9%2.7 $1.87
8/15/20253,890,000 shares $7.70 million -0.3%4.8%2.5 $1.98
7/31/20253,900,000 shares $7.92 million -15.6%4.8%2.5 $2.03
7/15/20254,620,000 shares $7.44 million -25.4%5.7%3.1 $1.61
6/30/20256,190,000 shares $7.80 million -43.5%7.6%4.6 $1.26
6/15/202510,950,000 shares $12.15 million +31.3%13.5%9.7 $1.11
5/31/20258,340,000 shares $8.97 million -12.1%10.3%7.7 $1.08
5/15/20259,490,000 shares $7.97 million +24.4%11.7%9.1 $0.84
4/30/20257,630,000 shares $6.49 million -19.5%9.4%7.3 $0.85
4/15/20259,480,000 shares $7.39 million -4.2%11.7%8.4 $0.78
3/31/20259,890,000 shares $9.03 million +12.1%12.2%8 $0.91
3/15/20258,820,000 shares $8.91 million -13.7%10.9%6.8 $1.01
2/28/202510,220,000 shares $11.96 million +14.7%13.0%7.6 $1.17
2/15/20258,910,000 shares $12.03 million +0.6%11.3%6.2 $1.35
1/31/20258,860,000 shares $12.67 million -18.0%11.2%5.6 $1.43
1/15/202510,800,000 shares $16.96 million +13.2%13.6%6.8 $1.57
12/31/20249,540,000 shares $15.17 million -2.7%12.1%6.5 $1.59
12/15/20249,800,000 shares $18.72 million +13.7%12.4%7.3 $1.91
11/30/20248,620,000 shares $18.88 million +16.2%10.9%6.7 $2.19
The cat is out the bag (Ad)

Almost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered separation packages to 8,500 workers, and Oracle is reportedly eliminating up to 30,000 positions. Goldman Sachs estimates 12,400 Americans are being financially displaced every single day. Analyst Porter Stansberry says the real driver runs deeper than AI - and two Nobel Prize winners have issued the same warning. He calls it the Final Displacement, and he's releasing a full investigation with specific companies to buy and sell before the next wave hits.tc pixel

Watch Porter Stansberry's full investigation into the Final Displacement now
11/15/20247,420,000 shares $14.77 million -25.4%9.4%6.1 $1.99
10/31/20249,940,000 shares $19.48 million -13.6%12.4%9.1 $1.96
10/15/202411,510,000 shares $22.44 million -1.4%14.4%12.8 $1.95
9/30/202411,670,000 shares $22.87 million +0.3%14.6%9 $1.96
9/15/202411,630,000 shares $24.66 million +2.2%14.6%7.9 $2.12
8/31/202411,380,000 shares $24.58 million -1.2%14.2%6.1 $2.16
8/15/202411,520,000 shares $23.96 million -7.3%14.4%5.3 $2.08
7/31/202412,430,000 shares $28.84 million +6.8%15.6%5 $2.32
7/15/202411,640,000 shares $24.79 million +13.6%14.6%4.6 $2.13
6/30/202410,250,000 shares $16.81 million -16.5%12.8%4.4 $1.64
6/15/202412,270,000 shares $21.96 million +6.6%15.4%5.3 $1.79
5/31/202411,510,000 shares $33.15 million +9.7%14.4%5.2 $2.88
5/15/202410,490,000 shares $38.18 million -1.4%13.1%5.6 $3.64
4/30/202410,640,000 shares $38.62 million -6.2%13.4%6.6 $3.63
4/15/202411,340,000 shares $46.15 million +11.2%14.2%7.1 $4.07
3/31/202410,200,000 shares $52.43 million +1.3%12.9%6.2 $5.14
3/15/202410,070,000 shares $54.08 million +7.2%12.7%6.1 $5.37
2/29/20249,390,000 shares $74.27 million -3.1%12.1%6.1 $7.91
2/15/20249,690,000 shares $67.83 million -4.3%12.5%6.2 $7.00
1/31/202410,120,000 shares $62.04 million +2.6%13.6%6.1 $6.13
1/15/20249,860,000 shares $53.64 million +2.3%13.2%5.6 $5.44
12/31/20239,640,000 shares $55.24 million -3.0%12.9%5.9 $5.73
12/15/20239,940,000 shares $60.53 million +0.5%13.7%6.5 $6.09
11/30/20239,890,000 shares $58.05 million +10.5%13.7%6 $5.87
11/15/20238,950,000 shares $41.80 million -8.5%12.4%5.3 $4.67
10/31/20239,780,000 shares $35.50 million +24.4%12.9%6 $3.63
10/15/20237,860,000 shares $32.93 million -28.9%10.4%5.3 $4.19
9/30/202311,050,000 shares $52.82 million +34.6%14.6%5.7 $4.78
9/15/20238,210,000 shares $48.11 million +20.9%10.8%2.4 $5.86
8/31/20236,790,000 shares $39.99 million -0.7%9.1%2.1 $5.89
8/15/20236,840,000 shares $45.01 million -6.2%9.2%2.2 $6.58
7/31/20237,290,000 shares $52.42 million -11.1%11.4%2.4 $7.19
7/15/20238,200,000 shares $51.66 million +31.8%12.8%2.9 $6.30
6/30/20236,220,000 shares $26.44 million -17.9%11.6%2.6 $4.25
6/15/20237,580,000 shares $34.87 million -4.3%14.2%10.1 $4.60
5/31/20237,920,000 shares $34.93 million +5.6%14.8%13.1 $4.41
5/15/20237,500,000 shares $33.75 million +9.2%14.0%13.9 $4.50
4/30/20236,870,000 shares $29.54 million +22.0%12.8%13.8 $4.30
4/15/20235,630,000 shares $25.79 million +7.9%10.5%11.1 $4.58
3/31/20235,220,000 shares $27.72 million +10.8%9.8%10.9 $5.31
3/15/20234,710,000 shares $24.30 million +10.1%8.8%9.2 $5.16
2/28/20234,280,000 shares $26.07 million -5.5%8.0%8.2 $6.09
2/15/20234,530,000 shares $30.62 million +3.7%8.5%8.4 $6.76
1/31/20234,370,000 shares $31.51 million No Change8.6%8 $7.21
1/15/20234,370,000 shares $31.55 million +14.7%8.6%7.6 $7.22
12/30/20223,810,000 shares $23.93 million +10.4%7.5%6.6 $6.28
12/15/20223,450,000 shares $26.67 million +3.3%6.8%6.1 $7.73
11/30/20223,340,000 shares $31.10 million +1.8%6.6%5.1 $9.31
11/15/20223,280,000 shares $33.13 million -9.4%6.5%4.9 $10.10
10/31/20223,620,000 shares $35.26 million -8.8%7.2%4.8 $9.74
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
10/15/20223,970,000 shares $37.12 million -1.5%7.8%5.2 $9.35
9/30/20224,030,000 shares $42.52 million +39.9%8.0%5.5 $10.55
9/15/20222,880,000 shares $36.84 million +15.2%5.7%3.9 $12.79
8/31/20222,500,000 shares $24.68 million -14.4%4.9%3.3 $9.87
8/15/20222,920,000 shares $29.26 million -24.4%5.8%3.8 $10.02
7/31/20223,860,000 shares $31.34 million +5.8%7.7%4.5 $8.12
7/15/20223,650,000 shares $26.13 million No Change7.3%4.4 $7.16
6/30/20223,650,000 shares $19.82 million +8.0%7.3%4.5 $5.43
6/15/20223,380,000 shares $17.91 million +0.6%6.8%4.3 $5.30
5/31/20223,360,000 shares $27.99 million +33.9%6.7%4.6 $8.33
5/15/20222,510,000 shares $22.51 million +7.7%5.1%3.7 $8.97
4/30/20222,330,000 shares $17.24 million -2.9%4.9%4.4 $7.40
4/15/20222,400,000 shares $19.54 million +1.7%5.0%4.4 $8.14
3/31/20222,360,000 shares $21.66 million +54.3%5.0%3.9 $9.18
3/15/20221,530,000 shares $13.11 million -53.4%3.2%2.5 $8.57
2/28/20223,280,000 shares $32.73 million +7.5%6.9%6.5 $9.98
2/15/20223,050,000 shares $35.35 million +1.3%6.5%6.1 $11.59
1/31/20223,010,000 shares $32.30 million +20.4%6.4%6.5 $10.73
1/15/20222,500,000 shares $29.03 million -5.3%5.3%6 $11.61
12/31/20212,640,000 shares $39.84 million +15.8%5.6%6.8 $15.09
12/15/20212,280,000 shares $38.51 million +18.1%4.8%5.5 $16.89
11/30/20211,930,000 shares $35.88 million +25.3%4.1%3.8 $18.59
11/15/20211,540,000 shares $33.46 million +32.8%3.3%2.7 $21.73
10/29/20211,160,000 shares $25.65 million -9.4%2.5%1.7 $22.11
10/15/20211,280,000 shares $26.68 million -22.4%2.7%1.7 $20.84
9/30/20211,650,000 shares $39.39 million +27.9%3.5%1.7 $23.87
9/15/20211,290,000 shares $35.54 million +29.0%2.8%1.2 $27.55
8/31/20211,000,000 shares $27.20 million +67.0%2.2%0.9 $27.20
8/13/2021598,800 shares $14.51 million No Change1.4%0.5 $24.23

CRBU Short Interest - Frequently Asked Questions

Short interest is the volume of Caribou Biosciences shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 11,594,287 shares of CRBU short. 12.78% of Caribou Biosciences' shares are currently sold short. Learn More on Caribou Biosciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRBU shares currently have a short interest ratio of 4.9. Learn More on Caribou Biosciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.78% of Caribou Biosciences' floating shares are currently sold short.

Caribou Biosciences saw a increase in short interest in July. As of July 15th, there was short interest totaling 11,594,287 shares, an increase of 20.4% from the previous total of 9,625,837 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.78% of Caribou Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Caribou Biosciences: Nuvectis Pharma, Inc. (7.98%), Maplight Therapeutics, Inc. (8.75%), Altimmune, Inc. (25.21%), Shattuck Labs, Inc. (11.16%), 4D Molecular Therapeutics, Inc. (23.60%), Tectonic Therapeutic, Inc. (17.05%), CytomX Therapeutics, Inc. (24.63%), Prime Medicine, Inc. (22.12%), Adlai Nortye Ltd. Sponsored ADR (8.80%), Neurogene Inc. (20.98%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.09 billion), Invesco QQQ ($48.11 billion), iShares Russell 2000 ETF ($23.61 billion), Sandisk Corporation ($12.69 billion), Nebius Group N.V. ($12.18 billion), Western Digital Corporation ($11.95 billion), SPDR S&P Biotech ETF ($11.73 billion), Quhuo Limited Sponsored ADR ($9.74 billion), VanEck Semiconductor ETF ($9.57 billion), and Financial Select Sector SPDR Fund ($8.43 billion). View all of the most shorted stocks.

Short selling CRBU is an investing strategy that aims to generate trading profit from Caribou Biosciences as its price is falling. CRBU shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Caribou Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRBU, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRBU, twice per month. The most recent reporting period available is July, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CRBU:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:CRBU is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 7/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Barricks gold output fell from 2 million ounces to 719000
Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...
Golden Portfolio | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
$8B is moving in... are you?
Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...
Awesomely | Sponsoredtc pixel
Trump's Next Move Could Shrink Your Dollar
There's a plan in Washington being called the 'Mar-a-Lago Accord' - a deliberate strategy to weaken the U.S. d...
Priority Gold | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel